In preclinical studies, for instance, overexpression of HYAL2 has been observed to stimulate tumor growth in a mouse model of astrocytoma [137], and Tan and co-workers have reported that HYAL1 overexpression promotes tumor growth and angiogenesis in a breast cancer xenograft model [138]. This evidence concerns the gene HYAL1 and neoplasm.